https://www.abc.net.au/news/2021-06-10/woman-dies-rare-blood-clots-astrazeneca-covid-vaccine/100205652
I'm still in favor of the vaccine. The death rate of COVID-19 cases is still around 2%. The mRNA vaccines appear to be safer.
Thursday, June 10, 2021
Wednesday, June 9, 2021
Friday, June 4, 2021
Thursday, June 3, 2021
EcoHealth Alliance
In April 2020 amid the COVID-19 pandemic caused by SARS-CoV-2, the NIH ordered EcoHealth Alliance to cease spending the remaining $369,819 from its current NIH grant at the request of the Trump administration due to their bat research relationship with the Wuhan Institute of Virology,
According to the reports, Peter Daszak, the president of EcoHealth Alliance, a research group that secured a grant to perform coronavirus research in Wuhan before the pandemic, had written a mail to Dr Fauci to say a "personal thank you" on behalf of his staff and collaborators after the latter had dismissed the idea that the pandemic started due to a lab accident in Wuhan.
Peter Daszak, a leading scientist whose organization had funded the coronavirus research in the Wuhan Institute of Virology, had thanked Dr Anthony Fauci for downplaying the theory that the coronavirus may have leaked from a lab.
According to the reports, Peter Daszak, the president of EcoHealth Alliance, a research group that secured a grant to perform coronavirus research in Wuhan before the pandemic, had written a mail to Dr Fauci to say a "personal thank you" on behalf of his staff and collaborators after the latter had dismissed the idea that the pandemic started due to a lab accident in Wuhan.
Shi Zhengli - Wikipedia
The SCMP also reported that Shi was the focus of personal attacks in Chinese social media who claimed the WIV was the source of the virus, leading Shi to post: "I swear with my life, [the virus] has nothing to do with the lab", and when asked by the SCMP to comment on the attacks, Shi responded: "My time must be spent on more important matters".[24] In a March 2020 interview with Scientific American, where she was called China's "Bat Woman",[25] Shi said "Bat-borne coronaviruses will cause more outbreaks", and "We must find them before they find us."[2] Leading virologists have explained that SARS-CoV-2 is most likely of natural origin, and that it is extremely unlikely that it leaked from a lab.[26][27] Shi's colleague Peter Daszak of the EcoHealth Alliance,[28] which studies emerging infectious diseases, has noted estimates that 1–7 million people in Southeast Asia who live or work in proximity to bats are infected each year with bat coronaviruses.[26][27] In an interview with Vox, Daszak comments, "There are probably half a dozen people that do work in those labs. So let's compare 1 million to 7 million people a year to half a dozen people; it's just not logical."[27] On July 31 Science Magazine published a interview with Shi in which she commented "to date, there is zero infection of all staff and students in our institute."[29] Asked by Science Magazine why the WIV conducts coronavirus experiments in BSL-4 labs when most other scientists work with coronaviruses BSL-2 or BSL-3 conditions, Shi explained that her group also used BSL-2 and BSL-3 laboratories for their coronavirus research, but that they had begun to use BSL-4 laboratories per government regulations after the pandemic.
I would personally welcome any form of visit, based on an open, transparent, trusting, reliable and reasonable dialogue. But the specific plan is not decided by me.
Tuesday, June 1, 2021
Fwd: Covid Treatments
Much of the illness associated with COVID-19 is due to the intense inflammatory and immune response that can occur with an infection. The most successful treatments so far have targeted this overzealous immune response.
Taken early in the disease, the inhaled corticosteroid budesonide has been shown to reduce the development of more severe disease.
In people hospitalised with COVID-19 requiring oxygen, the oral corticosteroid dexamethasone reduces the likelihood of death.
In the most severe cases — COVID patients admitted to ICU — the anti-inflammatory tocilizumab administered intravenously gives a person a better chance of survival.
But these treatments don't target SARS-CoV-2 itself; just the consequences of infection. Directly targeting the virus has proven to be more difficult
SARS-CoV-2 carries an enzyme, 3C-like protease (3CLpro), which plays a crucial role in the replication process. This protease is almost identical to the protease used by the SARS-CoV-1 (SARS) virus, and similar to the protease used by the Middle Eastern Respiratory Virus (MERS).
So a drug that could effectively target 3CLpro and prevent virus replication could be beneficial against multiple known coronaviruses, and possibly any that emerge in the future.
Pfizer/BioNtech are taking two drugs to clinical trials for COVID-19: PF-07304814, an intravenous injection for use in patients hospitalised with severe COVID-19 and PF-07321332, an oral agent, or pill, that could potentially be used earlier in the disease. Both are formulations of a 3CLpro inhibitor.
Could a simple pill beat COVID-19? Pfizer is giving it a go (theconversation.com)
An Israeli biotechnology company has claimed a 100% success rate in the first 10 patients treated with its drug as part of an early-stage clinical trial at Rambam Health Care Campus in Haifa.
Bonus's MesenCure, which consists of activated Mesenchymal Stromal Cells (MSCs) that are isolated from the adipose tissue of healthy donors, was found to reduce inflammation and alleviate respiratory and other symptoms in patients suffering from life-threatening respiratory distress brought on by COVID-19.
Monday, May 31, 2021
This $8 Trillion Coronavirus Mistake Could Kill 100%, w Stephen Fry.
The first three minutes talk about the danger of lab experiments on viruses. Then the video talks about other ways humans could destroy themselves.
Thursday, May 27, 2021
Indiana number of new cases
In six months, we have gone statewide from thousands of new cases per day to hundreds.
Monday, May 24, 2021
Saturday, May 22, 2021
Friday, May 21, 2021
Thursday, May 13, 2021
1 out of 500
Where do we stand compared to a year ago? We were looking at a death rate of about 6% compared to about 1.8% now. But the incredible number of cases means that 1/10 Americans have had an active case that we know of, with almost 1 out of every 500 Americans dying from the disease.
Wednesday, May 12, 2021
Thursday, May 6, 2021
Fwd: J&J blood clot in Utah
The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah.
A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release.
The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah.
"He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case.
The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after six cases were reported among over 6 million people who received the vaccine. The pause was lifted on April 23 after federal regulators determined the vaccine's continued use is safe.
Subscribe to:
Posts (Atom)